AFP and hepatocellular carcinoma: A Japanese study in 2020 proposed an even more simplified scoring system (0–2 points) based on level of AFP and age, with a 0.3, 6.2, and 18.3% incidence of HCC in patients with 0, 1, and 2 points, respectively.